Literature DB >> 19692681

Personalized medicine and inhibition of EGFR signaling in lung cancer.

Adi F Gazdar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19692681      PMCID： PMC3390194          DOI： 10.1056/NEJMe0905763

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy.

Authors:  Frances A Shepherd; Ming-Sound Tsao
Journal:  J Clin Oncol       Date:  2006-03-01       Impact factor: 44.544

3.  Toward noninvasive genomic screening of lung cancer patients.

Authors:  Lecia V Sequist; Jeffrey A Engelman; Thomas J Lynch
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

4.  Erlotinib in previously treated non-small-cell lung cancer.

Authors:  Frances A Shepherd; José Rodrigues Pereira; Tudor Ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

5.  Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.

Authors:  Federico Cappuzzo; Marileila Varella-Garcia; Hisayuki Shigematsu; Irene Domenichini; Stefania Bartolini; Giovanni L Ceresoli; Elisa Rossi; Vienna Ludovini; Vanesa Gregorc; Luca Toschi; Wilbur A Franklin; Lucio Crino; Adi F Gazdar; Paul A Bunn; Fred R Hirsch
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

Review 6.  Epidermal growth factor receptor mutations in lung cancer.

Authors:  Sreenath V Sharma; Daphne W Bell; Jeffrey Settleman; Daniel A Haber
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

7.  Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

Authors:  Tony S Mok; Yi-Long Wu; Sumitra Thongprasert; Chih-Hsin Yang; Da-Tong Chu; Nagahiro Saijo; Patrapim Sunpaweravong; Baohui Han; Benjamin Margono; Yukito Ichinose; Yutaka Nishiwaki; Yuichiro Ohe; Jin-Ji Yang; Busyamas Chewaskulyong; Haiyi Jiang; Emma L Duffield; Claire L Watkins; Alison A Armour; Masahiro Fukuoka
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

8.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

Review 9.  The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage.

Authors:  David J Chen; Chaitanya S Nirodi
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

10.  Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.

Authors:  Jeet Gandhi; Jianling Zhang; Yang Xie; Junichi Soh; Hisayuki Shigematsu; Wei Zhang; Hiromasa Yamamoto; Michael Peyton; Luc Girard; William W Lockwood; Wan L Lam; Marileila Varella-Garcia; John D Minna; Adi F Gazdar
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240
  10 in total
  60 in total

1.  Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening.

Authors:  Hemant K Roy; Hariharan Subramanian; Dhwanil Damania; Thomas A Hensing; William N Rom; Harvey I Pass; Daniel Ray; Jeremy D Rogers; Andrej Bogojevic; Maitri Shah; Tomasz Kuzniar; Prabhakar Pradhan; Vadim Backman
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

Review 2.  Lung cancer therapeutics that target signaling pathways: an update.

Authors:  M Roshni Ray; David Jablons; Biao He
Journal:  Expert Rev Respir Med       Date:  2010-10       Impact factor: 3.772

Review 3.  Imaging of lung cancer in the era of molecular medicine.

Authors:  Mizuki Nishino; David M Jackman; Hiroto Hatabu; Pasi A Jänne; Bruce E Johnson; Annick D Van den Abbeele
Journal:  Acad Radiol       Date:  2011-01-28       Impact factor: 3.173

4.  Genome-wide association studies and large-scale collaborations in epidemiology.

Authors:  Bruce M Psaty; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-07-11       Impact factor: 8.082

Review 5.  Cost effectiveness of pharmacogenomics: a critical and systematic review.

Authors:  William B Wong; Josh J Carlson; Rahber Thariani; David L Veenstra
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

6.  The evolving role of the pathologist in the management of lung cancer.

Authors:  Adi F Gazdar
Journal:  Lung Cancer Manag       Date:  2012

Review 7.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Authors:  Adi F Gazdar; Boning Gao; John D Minna
Journal:  Lung Cancer       Date:  2010-01-15       Impact factor: 5.705

Review 8.  [Molecular pathology of the lungs. New perspectives by next generation sequencing].

Authors:  C Vollbrecht; K König; L Heukamp; R Büttner; M Odenthal
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

Review 9.  The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.

Authors:  Xiao-Lan Liu; Rui Zuo; Wen-Bin Ou
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

10.  Magnetic barcode assay for genetic detection of pathogens.

Authors:  Monty Liong; Anh N Hoang; Jaehoon Chung; Nil Gural; Christopher B Ford; Changwook Min; Rupal R Shah; Rushdy Ahmad; Marta Fernandez-Suarez; Sarah M Fortune; Mehmet Toner; Hakho Lee; Ralph Weissleder
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.